Own blood injection for stubborn hives
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial tests whether injecting a small amount of your own blood (called autologous whole blood) can help reduce chronic hives that haven't improved with regular antihistamines. If you join, you may get this treatment and the researchers will see if it helps your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic hives (also called chronic idiopathic urticaria) that have not improved even with higher doses of antihistamines.
- Your hives are not due to a different cause, such as an allergy or physical trigger.
- You are not pregnant and are not breastfeeding.
- You have not taken corticosteroid or other immunosuppressive (immune-weakening) medications within the past 6 weeks.
- You do not have a history of bronchial asthma, and you are not currently taking blood thinners or NSAID pain relievers (like ibuprofen).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational pill called THB335 for adults whose hives (itchy welts) keep appearing despite taking antihistamines. The goal is to see if this treatment can reduce itching and hives and improve quality of life.
This study compares different treatment options for people with chronic hives (urticaria) that last longer than 6 weeks. It aims to find which treatment works best to reduce itching and welts.
This study tests a low-dose immune therapy (interleukin-2) for people with chronic hives that don't get better with standard allergy pills. If you are an adult with ongoing hives and itching despite daily antihistamines, this trial might offer a new treatment option.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This trial tests a new oral medication for chronic spontaneous urticaria (chronic hives). It is a placebo-controlled study, meaning some participants will get the new drug and some will get a placebo (a pill with no active ingredient). The goal is to see if the new drug is safe and how well it works, possibly providing a new treatment option for those whose hives are not controlled by current antihistamines.
Hear when a new Chronic Idiopathic Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.